Total m6A levels were also reported in a previous manuscript examining m6A in an AD model utilizing over-expression of only APP, which is a model that exhibits Aβ accumulation without corresponding MAPT pathology (Han et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.